ArticleVaccines2026

Preclinical Development of ARV-2001, an Intradermally Administered mRNA-Lipid Nanoparticle Immunotherapeutic for the Treatment of HPV-16-Positive Cervical High-Grade Squamous Intraepithelial Lesions.

Zhengxiang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.